Taylor, S. (2007). Psicolog�a de la Salud. M�xico, D.F.

: McGraw-Hill /
Interamericana Editores.

World Heatlh Organization. (2007). Global surveillance, prevention and control of

chronic respiratory diseases: A comprehensive approach.

Hambleton, K., Bafadhel, M., Rusell, R. (2016). Chronic obstructive pulmonary

disease: management of chronic disease. Medicine, 44(5), 310-313.

Rabe, F., Watz, H. (2017). Chronic obstructive pulmonary disease. Lancet, 389,
1931-40.

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. (2016). Global,
regional, and national incidence, prevalence, and years lived with disability for
328 diseases and injuries for 195 countries, 1990�2016: a systematic analysis for
the Global Burden of Disease Study 2016. Lancet, 390, 1211�59

World Health Organization. Chronic respiratory diseases. Burden of COPD.

http://www.who.int/respiratory/copd/burden/en/ (recuperado en Abril 30, 2018).

Mathers, C., Loncar, D. (2006). Projections of Global Mortality and Burden of

Disease from 2002 to 2030. PLoS Medicine, 3(11), 2011-30

Instituto Nacional de Estad�stica y Geograf�a. (2017). Estad�sticas a prop�sito del

d�a de muertos (2 de noviembre).
http://www.inegi.org.mx/saladeprensa/aproposito/2017/muertos2017_Nal.pdf
(recuperado en Abril 30, 2018).

Instituto Nacional de las Mujeres. (2016). Mujeres y hombres en M�xico 2016.

http://cedoc.inmujeres.gob.mx/documentos_download/MHM_2016.pdf (recuperado en Abril
30, 2018).

GBD 2015 Mortality and Causes of Death Collaborators. (2016). Global, regional, and
national life expectancy, all-cause mortality, and cause-specific mortality for 249
causes of death, 1980�2015: a systematic analysis for the Global Burden of Disease
Study 2015. Lancet, 388(10053), 1459-1544

Burney, P., Patel, J., Newson, R., Minelli, C., Naghavi, M. (2015). Global and
regional trends in COPD mortality, 1990�2010. European Respiratory Journal, 45,
1239�47.

World Health Organization. (2008). World Health Statistics 2008.

World Health Organization. (2017). WHO report on the global tobacco epidemic, 2017:
monitoring tobacco use and prevention policies.

No�-D�az, V., Garc�a-G�mez, L., Sansores, R., Villegas, A. (2014). Impacto del
tabaquismo y la EPOC sobre el funcionamiento cerebral. Neumolog�a y Cirug�a de
T�rax, 73(3), 196-204

Stephenson, J., Wertz, D., Gu, T., Patel, J., Dalal., A. (2017). Clinical and
economic burden of dyspnea and other COPD symptoms in a managed care setting.
International Journal of COPD, 12, 1947-59

Ehteshami-Afshar, S., FitzGerald, J., Doyle-Waters, M., Sadatsafavi, M. (2016). The

global economic burden of asthma and chronic obstructive pulmonary disease.
International Journal of Tuberculosis and Lung Disease, 20(1), 11-23
Guarascio, A., Ray, S., Finch, C., Self, T. (2013). The clinical and economic
burden of chronic obstructive pulmonary disease in the USA. ClinicoEconomics and
Outcomes Research, 5, 235�245

Mart�nez, D., Fern�ndez, M., Garc�a, M., P�rez, R. (2011). La carga econ�mica de la
EPOC. An�lisis de los costos a nivel internacional. Neumolog�a y Cirug�a de T�rax,
70(2), 118-26

Fern�ndez-Plata, R., Mart�nez-Brise�o, D., Garc�a-Sancho, C., Cano-Jim�nez, D.,

Ram�rez-Venegas, A., Sansores-Mart�nez, R., Torre-Bouscoulet, L., Casas-Medina, G.,
P�rez Padilla, R. (2016). M�todos para la estimaci�n de costos en salud de la EPOC:
resultados basales. Neumolog�a y Cirug�a de T�rax, 75(1), 4-11

Nev�rez-Sida, A., Castro-Bucio, A., Garc�a-Contreras, F., Cisneros-Gonz�lez, N.

(2017). Costos Medicos Directos en Pacientes Con Enfermedad Pulmonar Obstructiva
Cr�nica en Mexico Direct Medical Cost in Patients with Chronic Obstructive
Pulmonary Disease in Mexico. Value in Health Regional Issues, 14, 9-14